---

---

tags : N::A    symbols : TAK   

save search

---

Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| 0.68% | O: 0.23% H: 0.61% C: 0.46%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 1.74% | O: 0.83% H: 1.83% C: 0.89%
MIRM | News | $23.83 1.1% 1.09% 340K |

Health Technology

| 1.02% | O: -0.68% H: 2.52% C: 1.71%
report million reach treatment market

---

Neurvati Neurosciences Announces Appointment of Deborah Dunsire, MD, as Member and Chair of Company Board of Directors
Published: 2024-04-15 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -1.71% | O: -1.19% H: 0.26% C: -0.98%
company

---

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -9.07% | O: -0.07% H: 0.0% C: -0.96%
CNTG | $0.463 0.43% 0.43% 79K |

Commercial Services

| -34.29% | O: 1.43% H: 1.41% C: -1.41%
partnership genetic takeda disorders

---

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.67% | O: 0.21% H: 0.97% C: 0.7%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -3.84% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.01% | O: -1.58% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -4.52% | O: -0.7% H: 0.73% C: -0.16%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -7.71% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.4% | O: -0.02% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| -6.49% | O: -0.27% H: 1.26% C: 0.84%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -0.96% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

---

Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal and 10-Year Lease Extension With Longstanding Credit Tenant Takeda at the Alexandria Center at Kendall Square Mega Campus in Cambridge
Published: 2024-03-04 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -9.07% | O: -0.69% H: 0.35% C: 0.14%
ARE A | $115.69 -0.7% 0.0% 940K |

Finance

| -6.9% | O: -0.01% H: 1.98% C: 1.41%
extension

---

Plasma Therapy Global Market Report 2024 - Projected Compound Annual Growth Rate of 12.5%, with Market Set to Reach $0.88 Billion in 2028
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -10.18% | O: -0.2% H: 0.14% C: -0.48%
BAX | $39.47 -0.45% 0.0% 2.8M |

Health Technology

| -6.54% | O: -0.38% H: 0.14% C: -0.14%
KMDA | News | $5.05 -0.98% -0.99% 27K |

Health Technology

| -13.64% | O: 2.0% H: 2.28% C: 1.63%
ADMA 4 | $6.27 1.13% 1.12% 3.4M |

Health Technology

| 21.04% | O: 0.19% H: 2.5% C: 1.35%
report reach global set therapy growth market

---

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 7.24% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K |

Manufacturing

| 26.78% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -14.57% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -10.18% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -8.0% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -5.22% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -2.63% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -3.89% | O: -0.65% H: 1.63% C: 1.48%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -5.63% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.76% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 5.32% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -5.13% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

---

Polpharma Biologics' investigational biosimilar shows PK/PD comparability to inflammatory bowel disease blockbuster Entyvio®
Published: 2024-02-21 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -10.66% | O: -0.88% H: 0.34% C: 0.34%
entyvio disease biosimilar

---

Albumin Market to Reach $9.9 billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-15 (Crawled : 15:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| -1.65% | O: 3.61% H: 0.0% C: -0.13%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| -0.64% | O: -0.18% H: 1.09% C: 0.24%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -8.94% | O: -0.83% H: 0.38% C: 0.0%
reach research market

---

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6 |

Health Technology

| 9.6% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 10.28% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $55.65 0.02% 32K |

Professional, Scientific, and T...

| 11.08% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| 1.15% | O: 0.56% H: 1.3% C: 1.22%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.67% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.21% | O: -0.91% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.96% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -2.24% | O: 0.38% H: 2.44% C: 1.54%
BAX | $39.47 -0.45% 0.0% 2.8M |

Health Technology

| -0.38% | O: 0.33% H: 0.63% C: -0.28%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -4.61% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -4.7% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 0.28% | O: -1.1% H: 0.0% C: 0.0%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -25.55% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -14.24% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 12.32% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -7.42% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

---

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 12.87% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -12.2% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.48% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.14% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.55% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.21% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -1.49% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -1.65% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -3.85% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K |

Health Technology

| -22.73% | O: -1.15% H: 1.03% C: -1.5%
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| -5.79% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 0.22% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K |

Health Technology

| -5.43% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -9.49% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -20.58% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 11.63% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $360.11 0.47% 0.47% 330K |

Health Technology

| -8.27% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -8.66% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

---

Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
Published: 2024-02-07 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -6.5% | O: 0.07% H: 0.42% C: 0.07%
NBIX M | $132.03 -0.39% -0.39% 560K |

Health Technology

| -7.67% | O: -5.57% H: 6.04% C: 0.96%
financial results

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -12.32% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 1.76% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K |

Manufacturing

| 38.0% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -12.76% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -6.5% | O: 0.07% H: 0.42% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.04% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.03% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 3.02% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -0.67% | O: -0.14% H: 0.35% C: -1.12%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -2.7% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| -5.25% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -0.49% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K |

Health Technology

| -11.84% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 2.25% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -14.91% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.93% | O: 0.21% H: 0.49% C: -0.9%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -10.41% | O: -0.5% H: 0.26% C: -1.03%
report cancer research

---

Announcing Cognizant Flowsource™, a generative AI-enabled platform for powering modern engineering
Published: 2024-02-01 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -9.32% | O: 0.48% H: 0.0% C: -1.98%
CTSH | $67.4 0.4% 0.4% 4.9M |

Technology Services

| -12.55% | O: 0.3% H: 0.78% C: 0.69%
cognizant platform

---

Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published: 2024-01-26 (Crawled : 15:30) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -9.5% | O: -0.27% H: 0.38% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -11.8% | O: 0.29% H: 0.15% C: -0.13%
SRPT | $115.53 -0.88% -0.9% 640K |

Health Technology

| -3.67% | O: 0.69% H: 0.12% C: -1.75%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -16.79% | O: 0.0% H: 0.35% C: -0.88%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -13.32% | O: 0.1% H: 0.47% C: 0.39%
market

---

Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation
Published: 2024-01-25 (Crawled : 22:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -9.5% | O: -0.27% H: 0.38% C: 0.07%
CTSH | $67.4 0.4% 0.4% 4.9M |

Technology Services

| -13.87% | O: 0.33% H: 0.42% C: -1.63%
management cognizant application

---

Latest Phase III trial data investigating Cabometyx® in combination with immunotherapy to be presented at ASCO GU 2024
Published: 2024-01-22 (Crawled : 22:00) - globenewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -10.48% | O: -0.14% H: 0.17% C: -0.27%
cabometyx asco immunotherapy trial

---

Immunoglobulin Market to Reach $25.6 Billion, Globally, by 2032 at 6.6% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 00:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| -7.34% | O: -1.89% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -6.43% | O: -0.07% H: 0.18% C: -0.64%
GRFS | News | $6.29 -3.82% -3.97% 1.2M |

Health Technology

| -40.13% | O: 0.95% H: 2.27% C: 1.98%
reach research market

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -21.02% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -22.51% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -5.97% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $122.71 -0.03% 0.17% 5M |

Health Technology

| 26.75% | O: -0.42% H: 0.67% C: 0.25%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -1.64% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.17% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 23.82% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -2.45% | O: 0.2% H: 0.55% C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 12.6% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 1.27% | O: 1.07% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -14.47% | O: 0.08% H: 1.45% C: 1.17%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -0.88% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

NYC 4 | $5.91 -4.83% 14.38% 770 |

Finance

GBR | $1.42 31.48% 11.27% 990K |

Energy Minerals

DEO | News | $140.76 -0.02% 8.27% 560K |

Consumer Non-Durables

KUKE | $2.88 2.49% 7.64% 360K |

LYT | $4.22 4.72% 5.62% 1.4M |

SYY | $76.73 1.44% 5.49% 2.5M |

Distribution Services

TWI | $11.53 0.96% 4.94% 330K |

Producer Manufacturing

BTCM | $1.99 -6.13% 4.52% 75K |

Arts, Entertainment, and Recrea...

MPLN | $0.6502 -11.74% 4.51% 2.2M |

Finance

---

Your saved searches

---